In: Accounting
As per the information provided Jackson Pharmaceuticals Inc. is considering funding a research team to cure Lyme’s disease. Bill Mackenzie, executive VP of research, must ultimately make this decision.
Total price tag of the research program = $10M (million)
and there is no guarantee that it will be successful. In fact, Bill estimates only a 40% chance that they will find a cure.
Alternative 1: Sell the license to a chemical lab
Following statistical/mathematical techniques of risk evaluation in capital budgeting, we are here using Expected Net Present Value Mehod
In this method, Using the concept of probability in the risk analysis techniques, Probability distribution can be used to compute expected values by multiplying values with probability of each outcome.
Estimated Probability = Revenue x Estimated Probability
= 40% or 0.4
= 16
So Expected Value = $40M x 0.4 = $16M
Net Present Value = Casf Flows of Inflows - Cash Flow of Outflows
= 16 -10
=6
Expected Monetary Value or payoff from a successful R&D project (ALTERNATIVE 1) = $6M
Alternative 2: To produce the product themselves
Given that if production goes smoothly = revenue of $60M.
If there are production troubles = $20M revenue (30% Probabibilty)
Expected NPV = Revenue x Estimated Probability
Since there are 2 outcomes Multiply values with probability of each outcome
Expected NPV = 60 x 0.7 + 20x0.3
=42+6
=48
Now again Estimated Probability = Revenue x Estimated Probability
= 48 x 40%
= $19.2M
Net Present Value = Casf Flows of Inflows - Cash Flow of Outflows
= 19.2 - 10
=9.2
Expected Monetary Value or payoff from a successful R&D project (Alternative 2) = $9.2M
Since NPV is higher for Alternative 2, it must be chosen. Bill Mackenzie should make the final decision that Jackson Pharmaceuticals must produce the drug themselves